An experimental vaccine against Alzheimer’s disease has cleared its first
hurdle. Elan Pharmaceuticals of Dublin announced this week that the first 100
patients to receive the vaccine had not suffered any serious side effects. Some
showed an immune response. Codenamed AN-1792, the vaccine is a synthetic version
of the amyloid protein that clogs up the brains of patients. The company now
plans to test the vaccine in the US and Europe.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Red-light therapy does have health benefits but not the ones you think
2
Man destined for Alzheimer's may have been saved by accidental therapy
3
Woman in cancer remission without treatment in highly unusual case
4
We have figured out a new way to send messages into the past
5
Extinct relative of koalas discovered in Western Australia
6
Hantavirus: Where has the deadly cruise ship outbreak come from?
7
The 50-year quest to create a quantum spin liquid may finally be over
8
Huge landslide in Alaska caused 481m-high tsunami
9
The greatest David Attenborough documentaries you really need to watch
10
Specific cognitive training has 'astonishing' effect on dementia risk
